References
- Fournier CN, James V, Glass JD. Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:311–6. Available at: 10.1080/21678421.2022.2153607
- Draak THP, de Greef BTA, Faber CG, Merkies ISJ. The minimum clinically important difference: which direction to take. Eur J Neurol. 2019;26:850–5. Available at: 10.1111/ene.13941
- Vázquez‐Costa JF, Hervás D. Minimal detectable change and minimal clinically important difference in spinal muscular atrophy patients. Eur J Neurol. 2021;28:e40–e41. 10.1111/ene.14780
- de Vet HCW, Mokkink LB, Terwee CB. Minimal clinically important difference (MCID). In: Michalos AC, ed. Encyclopedia of quality of life and well-being research. Netherlands: Springer; 2014;4071–4072. Available at: 10.1007/978-94-007-0753-5_1812
- Brooks BR. Functional scales: Summary. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2009;3 Suppl 1(SUPPL. 1), S13-8. Available at: 10.1080/146608202320374165
- Franchignoni F, Mora G, Giordano A, Volanti P, Chiò A. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013;84:1340–5. Available at: https://jnnp.bmj.com/content/84/12/1340
- van Eijk RPA, de Jongh AD, Nikolakopoulos S, McDermott CJ, Eijkemans MJC, Roes KCB, et al. An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials. Amyotroph Lateral Scler Frontotemporal Degener. 2021; 22;300–7. 10.1080/21678421.2021.1879865
- Terwee CB, Peipert JD, Chapman R, Lai JS, Terluin B, Cella D, et al. Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual Life Res. 2021;30:2729–54. Available at:/pmc/articles/PMC8481206/